Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1983 3
1985 1
1986 2
1987 11
1988 33
1989 32
1990 46
1991 53
1992 56
1993 61
1994 62
1995 68
1996 76
1997 84
1998 105
1999 117
2000 93
2001 98
2002 119
2003 135
2004 119
2005 120
2006 132
2007 108
2008 137
2009 132
2010 133
2011 144
2012 153
2013 135
2014 108
2015 56
2016 62
2017 65
2018 111
2019 115
2020 112
2021 154
2022 149
2023 132
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

3,591 results

Results by year

Filters applied: . Clear all
The following terms were not found in PubMed: Keraskian, Moojembari
Page 1
Did you mean adis kraskian mojembari (1 results)?
Sparsentan: First Approval.
Syed YY. Syed YY. Drugs. 2023 Apr;83(6):563-568. doi: 10.1007/s40265-023-01864-x. Drugs. 2023. PMID: 37022667 Free PMC article. Review.
Ritlecitinib: First Approval.
Blair HA. Blair HA. Drugs. 2023 Sep;83(14):1315-1321. doi: 10.1007/s40265-023-01928-y. Drugs. 2023. PMID: 37556041 Free PMC article. Review.
Lenacapavir: First Approval.
Paik J. Paik J. Drugs. 2022 Sep;82(14):1499-1504. doi: 10.1007/s40265-022-01786-0. Drugs. 2022. PMID: 36272024 Free PMC article. Review.
Tapinarof Cream 1%: First Approval.
Keam SJ. Keam SJ. Drugs. 2022 Jul;82(11):1221-1228. doi: 10.1007/s40265-022-01748-6. Drugs. 2022. PMID: 35939180 Free PMC article. Review.
Spesolimab: First Approval.
Blair HA. Blair HA. Drugs. 2022 Nov;82(17):1681-1686. doi: 10.1007/s40265-022-01801-4. Drugs. 2022. PMID: 36418672 Free PMC article. Review.
Potential impacts of synthetic food dyes on activity and attention in children: a review of the human and animal evidence.
Miller MD, Steinmaus C, Golub MS, Castorina R, Thilakartne R, Bradman A, Marty MA. Miller MD, et al. Environ Health. 2022 Apr 29;21(1):45. doi: 10.1186/s12940-022-00849-9. Environ Health. 2022. PMID: 35484553 Free PMC article. Review.
For four dyes where adequate dose-response data from animal and human studies were available, comparisons of the effective doses in studies that measured behavioral or brain effects following exposure to synthetic food dyes indicate that the basis of the ADIs may not be ad …
For four dyes where adequate dose-response data from animal and human studies were available, comparisons of the effective doses in studies …
Abrocitinib: First Approval.
Deeks ED, Duggan S. Deeks ED, et al. Drugs. 2021 Dec;81(18):2149-2157. doi: 10.1007/s40265-021-01638-3. Drugs. 2021. PMID: 34807428 Free PMC article. Review.
Tofacitinib.
Adis Editorial. Adis Editorial. Drugs R D. 2010;10(4):271-84. doi: 10.2165/11588080-000000000-00000. Drugs R D. 2010. PMID: 21171673 Free PMC article. Review.
REGN-EB3: First Approval.
Markham A. Markham A. Drugs. 2021 Jan;81(1):175-178. doi: 10.1007/s40265-020-01452-3. Drugs. 2021. PMID: 33432551 Free PMC article. Review.
Tralokinumab: First Approval.
Duggan S. Duggan S. Drugs. 2021 Sep;81(14):1657-1663. doi: 10.1007/s40265-021-01583-1. Drugs. 2021. PMID: 34406631 Free PMC article. Review.
3,591 results